|
Quotes & Info
|
| CHTP > SEC Filings for CHTP > Form 8-K on 31-May-2012 | All Recent SEC Filings |
31-May-2012
Other Events, Financial Statements and Exhibits
On May 31, 2012 Chelsea Therapeutics International, Ltd. issued a press release announcing top-line results of its Phase II trial of CH-4051 in patients with rheumatoid arthritis. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated May 31, 2012.
|
|